General & Plastic Surgery Devices - Israel

  • Israel
  • In Israel, the General & Plastic Surgery Devices market market is expected to witness significant growth in the coming years.
  • According to projections, the revenue in this market is estimated to reach US$152.70m by 2024.
  • Furthermore, it is anticipated that the market will continue to expand with an annual growth rate of 6.52%, resulting in a market volume of US$209.40m by 2029.
  • When compared to other countries on a global scale, the United States is expected to generate the highest revenue in the General & Plastic Surgery Devices market market.
  • In 2024, the revenue the United States is projected to amount to US$9,844.00m.
  • This indicates the dominance and significance of the US market in this particular market.
  • Israel's advanced medical technology sector has led to a surge in demand for General & Plastic Surgery Devices.

Key regions: Europe, Japan, United Kingdom, Netherlands, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The General & Plastic Surgery Devices market in Israel has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in Israel have played a key role in driving the growth of the General & Plastic Surgery Devices market. Israeli consumers have shown a strong interest in cosmetic procedures and are increasingly seeking out plastic surgery to enhance their appearance. This growing demand for cosmetic procedures has created a need for advanced and innovative surgical devices and technologies. Trends in the market have also contributed to the growth of the General & Plastic Surgery Devices market in Israel. Technological advancements have led to the development of new and improved surgical devices that offer more precise and effective results. Israeli healthcare professionals are adopting these advanced devices to meet the increasing demand for cosmetic procedures. Additionally, there has been a shift towards minimally invasive procedures, which require specialized devices and equipment. This trend has further boosted the demand for General & Plastic Surgery Devices in the Israeli market. Local special circumstances have also played a role in the development of the General & Plastic Surgery Devices market in Israel. The country has a well-established healthcare system with high standards of care, which has created a favorable environment for the growth of the market. Additionally, Israel is known for its strong research and development capabilities, particularly in the field of medical technology. This has led to the emergence of innovative surgical devices that are developed and manufactured locally, further driving the growth of the market. Underlying macroeconomic factors have also contributed to the growth of the General & Plastic Surgery Devices market in Israel. The country has a strong economy and a high standard of living, which has increased the affordability of cosmetic procedures for many Israeli consumers. Additionally, the Israeli government has implemented policies to encourage medical tourism, attracting patients from around the world who are seeking high-quality and cost-effective cosmetic procedures. This has created a significant demand for General & Plastic Surgery Devices in the Israeli market. In conclusion, the General & Plastic Surgery Devices market in Israel has experienced significant growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing demand for cosmetic procedures, technological advancements, favorable local conditions, and strong macroeconomic factors have all contributed to the development of the market in Israel.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)